Mepilex Lite Dressing for radiation skin damage on anal area
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial tests a special wound dressing (Mepilex Lite) to treat skin burns from radiation therapy in patients with rectal cancer. It may help heal the skin around the anal canal more comfortably.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with rectal cancer
- Your doctor has recommended radiation therapy
- This is your first time receiving radiation and you have developed grade 2 or higher skin irritation (redness, swelling, peeling) in the anal area
- You are 18 years old or older
- You do not have severe allergies to wound dressing materials
- You are able to complete the full radiation treatment without stopping early
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a liquid dressing that is applied to the rectum to help heal damage caused by radiation therapy. It may reduce bleeding, pain, and other symptoms of chronic radiation proctitis.
This trial tests a shorter course of radiation therapy followed by a combination of chemotherapy, immunotherapy, and a pain-relief medication, compared to the standard approach. It is for people with a certain type of rectal cancer that has not spread.
This trial tests if a special film placed on the skin can reduce radiation side effects in people who have had breast cancer surgery and are now getting radiation therapy.
This study tests whether giving a steroid medication (dexamethasone) as an enema can help reduce the side effect of radiation treatment on the rectal area. If you are getting radiation for rectal cancer and are bothered by rectal irritation, this might be a helpful addition to your care.
This trial tests a combination of short-course radiation, chemotherapy (capecitabine), and two immunotherapy drugs (PD-1 and CTLA-4 inhibitors) for people with early-stage rectal cancer who want to avoid surgery and keep their anus. The goal is to see if this treatment can shrink the tumor enough to avoid major surgery.
This Phase 2 study tests whether a shorter course of radiation, combined with chemotherapy (CAPOX) and an immunotherapy drug (tislelizumab), can control middle and low rectal cancer. It may also help people who strongly want to keep their anus, if the cancer and overall health fit the study rules.
Hear when a new Rectal Cancer, Radiotherapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.